Positive interim Phase 2 results for COVID-19 vaccine from Medicago and GSK 21-May-2021 By Jane Byrne Canadian biotechnology company, Medicago, announced positive interim Phase 2 results this week for its plant-derived COVID-19 vaccine, which has been tested in combination with GSK’s pandemic adjuvant.